文献速递胃肠外科肝胆胰外科疝与腹壁外科

达芬奇单孔机器人系统在普通外科的应用与前景:范围综述

Da Vinci single-port robotic system current application and future perspective in general surgery: A scoping review.
PubMed 文献 · Surg Endosc · 2024-08-07

结果显示DVSP在结直肠、胆囊切除、腹壁修复、上消化道、肝、胰、乳腺和甲状腺手术中可行且安全,疝修复、胆囊切除和结直肠手术是最常进行的干预。部分研究报告相比多孔机器人手术有出院更快、手术时间更短和术后疼痛更轻的优势,但需更大样本和更长随访验证长期结局。

要点

  • DVSP在普通外科多种手术中显示可行性和安全性。
  • 疝修复、胆囊切除和结直肠手术是DVSP最常应用的术式。
  • 部分研究提示DVSP可能加快出院、缩短手术时间并减轻疼痛。

核心结论

  • DVSP在普通外科手术中应用五年后已证明可行性和安全性。
  • 疝修复、胆囊切除和结直肠手术是该系统最常进行的干预。
  • 期待更大样本和更长随访研究提供长期结局的全面数据。

研究设计与样本

  • 范围综述,检索PubMed、Embase和Ebsco数据库截至2024年3月,注册于PROSPERO(CRD42024536430),遵循PRISMA-Scr指南。

主要发现

  • 应用领域包括经腹和经肛结直肠、胆囊切除、腹壁修复、上胃食管、肝、胰、乳腺和甲状腺手术。
  • 报告的围手术期和短期结局良好,多种手术可安全实施。
  • 部分研究组发现相比多孔机器人手术,DVSP有出院更快、手术时间更短和术后疼痛更轻的优势。

临床怎么用

  • DVSP可用于普通外科的疝修复、胆囊切除和结直肠手术等术式,但需注意其当前在部分国家仅获批泌尿和经口手术,普通外科应用多属实验方案。
  • CE认证后DVSP将进入欧洲市场,临床引入时应关注长期结局如切口疝发生率。

局限性

  • 需更大样本量和更长随访期的研究来提供长期结局的全面数据。
  • 原文未报告纳入研究的偏倚风险或证据质量评价。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The da Vinci Single-Port Robot System (DVSP) allows three robotic instruments and an articulated scope to be inserted through a single small incision. It received FDA approval in 2014 and was first introduced in 2018. The aim of this new system was to overcome the limitations of single-incision laparoscopic and robotic surgery. Since then, it has been approved for use only for urologic and transoral surgeries in some countries. It has been used as part of experimental protocols in general surgery. OBJECTIVE: By obtaining the CE mark at the end of January 2024, DVSP will soon enter the European market. This review aims to comprehensively describe the applications of DVSP in general surgery. DESIGN: A search of PubMed, Embase, and Ebsco databases up to March 2024 was conducted, with registration in PROSPERO (CRD42024536430), following the preferred reporting items for Systematic reviews and Meta-analyses for scoping review (PRISMA-Scr) guidelines. All the studies about the use of DVSP in general surgery were included. RESULTS: Fifty-six studies were included. The following surgical areas of use were identified: transabdominal and transanal colorectal, cholecystectomy, abdominal wall repair, upper gastroesophageal tract, liver, pancreas, breast, and thyroid surgery. The reported surgical and short-term outcomes are promising; a wide range of procedures have been performed safely. Some groups have found advantages, such as faster discharge, shorter operative time, and less postoperative pain compared to multiport robotic surgery. CONCLUSION: Five years after its initial clinical applications, the use of the DVSP in general surgery procedures has demonstrated feasibility and safety. Hernia repair, cholecystectomy, and colorectal surgery emerge as the most frequently conducted interventions with this robotic system. Nevertheless, there is anticipation for further studies with larger sample sizes and extended follow-up periods to provide more comprehensive insights and data on the long-term outcomes, including the incidence of incisional hernia.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Celotto F, Ramacciotti N, Mangano A, et al. Da Vinci single-port robotic system current application and future perspective in general surgery: A scoping review. Surg Endosc. 2024. PMID: 39110221. doi:10.1007/s00464-024-11126-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。